Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national
national blog main
national top stories
san francisco blog main
san francisco top stories
2
×
alder biopharmaceutical
allergan
american academy of neurology
amgen
atogepant
biohaven
biotech
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cancer
clinical trials
crispr
crispr therapeutics
crispr-cas9
detroit blog main
detroit top stories
drugs
editas
editas medicine
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
impel neuropharma
indiana blog main
indiana top stories
What
new
2
×
potential
2
×
approval
arguments
big
cancer
cas
cells
class
commercialized
companies
competitors
crispr
decades
defect
drive
drug
drugs
edited
editing
fda
fears
flag
gene
genetic
guardian
human
known
lab
make
malfunction
medicine
meeting
migraine
nature
neuro
nicknamed
occurs
oral
papers
Language
Current search:
potential
×
new
×
" san francisco top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
